GNH USA

Europe — EMA

Octreoscan (Indium In-111 Pentetreotide)

Indium In-111 pentacarbamoyl‑methyl‑DTPA‑octreotide (Indium In-111 pentetreotide), the active ingredient in Octreoscan, is a somatostatin analog presented as a solution for intravenous use.

Request sourcing

1
Pack/s

What is Indium In-111 Pentetreotide?

Indium In-111 pentacarbamoyl‑methyl‑DTPA‑octreotide (Indium In-111 pentetreotide), the active ingredient in Octreoscan, is a somatostatin analog presented as a solution for intravenous use. It binds to somatostatin receptors on neuroendocrine tumour cells to aid diagnostic imaging. GNH USA supplies Octreoscan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

GNH USA supplies Octreoscan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

What is Indium In-111 Pentetreotide used for?

Octreoscan is used in the diagnostic pathway for neuro‑   ...

What are the side effects of Indium In-111 Pentetreotide?

Common  

What precautions apply to Indium In-111 Pentetreotide?

Precautions 

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Indium In-111 Pentetreotide
Route
Intravenous Use
Manufacturer
Curium Netherlands B.V.
Origin
EU

Related products